Moneycontrol PRO
Outskill Genai
HomeNewsBusinessEarningsSequent Scientific slumps 6% after Q1 loss widens to Rs 34.7 cr

Sequent Scientific slumps 6% after Q1 loss widens to Rs 34.7 cr

Revenue from operations slipped 2.3 percent to Rs 333.2 crore in the first quarter of FY24 compared to Rs 341.3 crore in the year-ago period.

August 11, 2023 / 10:29 IST
The animal health company had posted a consolidated net loss of Rs 15.3 crore in Q1 FY23
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Sequent Scientific tumbled nearly 6 percent in morning trade on August 11 after the company reported widening of its net loss to Rs 34.7 crore for the quarter ended June 2023.

    At 10 am, shares of the company were trading 5.93 percent down at Rs 95.04 on the BSE.

    The animal health (active pharmaceutical ingredients and formulations) company had posted a consolidated net loss of Rs 15.3 crore in Q1 FY23, it said in a post-market hours filing on August 10.

    Revenue from operations slipped 2.3 percent to Rs 333.2 crore in the first quarter of FY24 compared to Rs 341.3 crore in the year-ago period.

    EBITDA (earnings before interest, taxes, depreciation, and amortisation) fell 73.6 percent to Rs 2.9 crore as against Rs 11 crore in Q1 FY23.

    EBITDA margin stood at 0.9 percent compared to 3.2 percent in the same quarter of the previous fiscal.

    Follow our live blog for all the market action

    The company said there were exceptional expenditures amounting to Rs 23.5 crore -- Rs 20.7 crore pertaining to domain expert fees towards revamping its API manufacturing operations and Rs 2.8 crore towards Tarapur settlement pay and asset write‐downs.

    “Our programme for driving operational excellence in APIs is on course and we expect to see steady margin improvement. Our manufacturing footprint has been further optimised with the discontinuance of manufacturing operations in Tarapur,” it added.

    The company said while Q1 FY24 has seen muted performance in sales on account of some transitionary connectivity challenges as it undertook network optimisation during the quarter, it expects acceleration in revenues and margins during the year.

    Shares of Sequent Scientific are up 7 percent on YTD basis, but the 1-year return stands at (-) 8.65 percent.

    Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Moneycontrol News
    first published: Aug 11, 2023 10:28 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347